Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study

NCT: NCT06172699 · COMPLETED

NCT IDNCT06172699
StatusCOMPLETED
Start Date2024-01-01
Completion2025-11-10

Brief Summary

This is a prospective, non-randomized, multi-center, real-world post-market study to collect and evaluate data regarding the performance of the enhanced atrial fibrillation detection algorithm of the Assert-IQTM Implantable Cardiac Monitor (ICM) device.

Frequently Asked Questions

What is Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study?

Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study is a clinical trial registered under NCT06172699. Current status: COMPLETED.

What is the status of NCT06172699?

The current status of NCT06172699 (Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study) is: COMPLETED.

When did Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study start?

Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study started on 2024-01-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑